Letter: Tackling drugs
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Sir: Kathy Marks questions the value of the "drugs tsar" ("Is he worth it?", 26 May). We take a rather different view.
Independent research shows that treatment works and that its costs are more than outweighed by its benefits, with one recent study estimating a saving of pounds 3 for every pounds 1 spent. We welcome the fact that in his first annual report Mr Hellawell reaffirmed the position of treatment at the heart of his strategy and set new targets for its expansion over the next decade.
We have our concerns of course. If it is to be effective, treatment must be targeted to the particular needs of the individual and must be delivered to a high standard by well-trained and supervised staff. It also needs to be properly funded. Whilst the government has pledged more money for treatment the amounts are woefully inadequate. And the funding system is a mess, with too much bureaucracy, confusion about who is responsible for paying, and excessive focus on short-term costs rather than longer- term benefits.
We will continue to press for the changes necessary if we are to have any chance of winning the battle against drug addiction. But Mr Hellawell has placed treatment and its expansion at the heart of his strategy and has secured some (albeit not enough) additional funding from the Treasury to help pay for it. For this we and the addicts we represent must give credit where it is due.
SIMON SHEPHERD
Chief Executive
European Association for the Treatment of Addiction
Rugby, Warwickshire
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments